The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review

Carregando...
Imagem de Miniatura
Citações na Scopus
56
Tipo de produção
article
Data de publicação
2013
Editora
SAGE PUBLICATIONS LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
CRISTIANO, E.
ROJAS, J. I.
ROMANO, M.
FRIDER, N.
MACHNICKI, G.
GIUNTA, D. H.
CORONA, T.
FLORES, J.
GRACIA, F.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
MULTIPLE SCLEROSIS JOURNAL, v.19, n.7, p.844-854, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The incidence and prevalence of multiple sclerosis (MS) varies geographically as shown through extensive epidemiological studies performed mainly in developed countries. Nonetheless, scant data is available in Latin America and the Caribbean (LAC). The objective of this review is to assess epidemiological data of MS in LAC. We conducted a systematic review of published articles and gray literature from January 1995 to May 2011. Twenty-two studies met the inclusion criteria after full-text review. Incidence data were found in only three studies and ranged from 0.3 to 1.9 annual cases per 100,000 person-years. Prevalence was reported in 10 studies and ranged from 0.83 to 21.5 cases per 100,000 inhabitants. The most prevalent subtype of MS was the relapsing-remitting form (48% to 91% of the series). No data about mortality were found. This study showed low frequency for MS in LAC compared with North American and European countries. The role of environmental and genetic factors should be well studied, providing new insights about its etiology.
Palavras-chave
Multiple sclerosis, Latin America, epidemiology, incidence, prevalence
Referências
  1. Abad P, 2010, NEUROLOGIA, V25, P309, DOI 10.1016/j.nrl.2009.12.005
  2. Alves-Leon SV, 2008, ARQ NEURO-PSIQUIAT, V66, P671, DOI 10.1590/S0004-282X2008000500012
  3. Arruda WO, 2001, ARQ NEURO-PSIQUIAT, V59, P165, DOI 10.1590/S0004-282X2001000200002
  4. Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7
  5. Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141
  6. Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100
  7. Barahona J, 2004, ARQ NEURO-PSIQUIAT, V62, P11
  8. Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624
  9. Cabrera-Gomez JA, 1999, REV NEUROLOGIA, V28, P849
  10. Cabrera-Gomez JA, 1998, REV NEUROLOGIA, V26, P723
  11. Callegaro D, 2001, ACTA NEUROL SCAND, V104, P208, DOI 10.1034/j.1600-0404.2001.00372.x
  12. Cardoso E, 2006, ARQ NEURO-PSIQUIAT, V64, P727, DOI 10.1590/S0004-282X2006000500005
  13. Cordova J, 2007, CLIN NEUROL NEUROSUR, V109, P146, DOI 10.1016/j.clineuro.2006.07.006
  14. Corona T, 2006, NEUROEPIDEMIOLOGY, V26, P1, DOI 10.1159/000089230
  15. Correale J, 2009, MULT SCLER, V15, pS15
  16. Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033
  17. Cristiano E, 2009, EUR J NEUROL, V16, P183, DOI 10.1111/j.1468-1331.2008.02375.x
  18. Cristiano E, 2008, EUR J NEUROL, V15, P1273, DOI 10.1111/j.1468-1331.2008.02330.x
  19. Cristiano E, 2010, EUR J NEUROL, V17, P479, DOI 10.1111/j.1468-1331.2009.02846.x
  20. DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
  21. Diaz V, 2012, ACTA NEUROL SCAND, V125, P71, DOI 10.1111/j.1600-0404.2011.01571.x
  22. Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5
  23. Egger M, 1997, BRIT MED J, V315, P629
  24. Ferreira MLB, 2004, ARQ NEURO-PSIQUIAT, V62, P1027, DOI 10.1590/S0004-282X2004000600018
  25. Finkelsztejn A, 2009, ARQ NEURO-PSIQUIAT, V67, P1071, DOI 10.1590/S0004-282X2009000600021
  26. FOWKES FGR, 1991, BRIT MED J, V302, P1136
  27. Fragoso Yara Dadalti, 2007, Rev. bras. epidemiol., V10, P479, DOI 10.1590/S1415-790X2007000400005
  28. GORODEZKY C, 1985, TISSUE ANTIGENS, V25, P38
  29. Gracia F, 2009, NEUROEPIDEMIOLOGY, V32, P287, DOI 10.1159/000204912
  30. Kawano Castillo J, 2009, REV MED HERED, V20, P146
  31. Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9
  32. Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8
  33. Kurtzke JF, 2000, NEUROL SCI, V21, P383, DOI 10.1007/s100720070055
  34. Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
  35. Lublin FD, 1996, NEUROLOGY, V46, P907
  36. McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032
  37. Melcon MO, 2008, MULT SCLER J, V14, P656, DOI 10.1177/1352458507085801
  38. Melcon MO, 2012, MULT SCLER
  39. Mirsattari SM, 2001, NEUROLOGY, V56, P317
  40. Moreira MA, 2000, ARQ NEURO-PSIQUIAT, V58, P460, DOI 10.1590/S0004-282X2000000300010
  41. Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6
  42. Patrucco L, 2009, EUR J NEUROL, V16, P427, DOI 10.1111/j.1468-1331.2008.02523.x
  43. Polman CH, 2010, ANN NEUROL, V69, P292, DOI 10.1002/ANA.22366
  44. Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.206703
  45. POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302
  46. Pugliatti M, 2002, CLIN NEUROL NEUROSUR, V104, P182, DOI 10.1016/S0303-8467(02)00036-7
  47. Pugliatti M, 2005, NEUROEPIDEMIOLOGY, V25, P129, DOI 10.1159/000086677
  48. Risco J, 2011, MULT SCLER J, V17, P1055, DOI 10.1177/1352458511405562
  49. Rivera-Olmos VM, 2007, REV MEX NEUROCI, V8, P49
  50. Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011
  51. Sanchez JL, 2000, REV NEUROLOGIA, V31, P1101
  52. Sanchez JL, 2001, MULT SCLER, V7, P227
  53. STRACHAN DP, 1989, BRIT MED J, V299, P1259
  54. Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
  55. Takkouche B, 1999, AM J EPIDEMIOL, V150, P206
  56. Toro J, 2007, NEUROEPIDEMIOLOGY, V28, P33, DOI 10.1159/000097854
  57. Van Den SK, 2004, NEUROEPIDEMIOLOGY PR, P188
  58. Velazquez-Quintana M, 2003, REV NEUROLOGIA, V36, P1019
  59. von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X